Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Small (Weinheim an Der Bergstrasse, Germany)|March 30, 2021
Core-Multishell-Structured Digital-Gradient Cathode Materials with Enhanced Mechanical and Electrochemical DurabilityYoungho Shin, Sangjin Maeng, Youngmin Chung, et al.Med (New York, N.Y.)|January 13, 2024
A systematic analysis of the landscape of synthetic lethality-driven precision oncologyAlejandro A Schäffer, Youngmin Chung, Ashwin V Kammula, et al.ACS Applied Materials & Interfaces|February 26, 2016
Thermal Stability and Reactivity of Cathode Materials for Li-Ion BatteriesYiqing Huang, Yuh-Chieh Lin, David M Jenkins, et al.Cancer Research|October 30, 2025
Path2Omics Enhances Transcriptomic and Methylation Prediction Accuracy from Tumor HistopathologyDanh-Tai Hoang, Eldad D Shulman, Saugato Rahman Dhruba, et al.ACS Omega|August 29, 2019
Electrochemical Performance of Nanosized Disordered LiVOPO4Yong Shi, Hui Zhou, Ieuan D Seymour, et al.Cell|April 15, 2021
Synthetic lethality-mediated precision oncology via the tumor transcriptomeJoo Sang Lee, Nishanth Ulhas Nair, Gal Dinstag, et al.Journal for Immunotherapy of Cancer|October 18, 2023
Increased interleukin-6/C-reactive protein levels are associated with the upregulation of the adenosine pathway and serve as potential markers of therapeutic resistance to immune checkpoint inhibitor-based therapies in non-small cell lung cancerAbdul Rafeh Naqash, Justin D McCallen, Emma Mi, et al.Cell|May 9, 2026
AI-predicted spatial transcriptomics unlocks breast cancer biomarkers from pathologyEldad D Shulman, Emma M Campagnolo, Roshan Lodha, et al.Cancer Discovery|July 27, 2022
AXL and Error-Prone DNA Replication Confer Drug Resistance and Offer Strategies to Treat EGFR-Mutant Lung CancerAshish Noronha, Nishanth Belugali Nataraj, Joo Sang Lee, et al.Pageof 1